TPO Receptor Agonists: Treatment Considerations

Ivy Altomare, MD; Keith R. McCrae, MD; and Terry Gernsheimer, MD, discuss clinical considerations for treating appropriate adult patients with idiopathic thrombocytopenia purpura with thrombopoietin receptor agonists in the second-line setting.